NRT + Quit Practice Strategies for Smoking Cessation
(ON-DEQ Trial)
Trial Summary
What is the purpose of this trial?
Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date. This is problematic because few smokers are ready to set a quit date at any given time, and a smoker's stated intention to quit can change rapidly. One novel potential treatment strategy is to foster practice quitting (PQ), defined as attempting to not smoke for a few hours or days, without pressure or expectation to permanently quit. Although a growing body of evidence supports the role of practice quitting in fostering permanent quit attempts and cessation, there is a significant knowledge gap regarding which treatment strategies should be used to engage smokers in practice quitting. The proposed study will test the role of PQ counseling vs. Motivational Interviewing (MI) counseling, and NRT sampling (four-week supply of nicotine lozenges and patches) vs. none.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have any FDA contraindications for nicotine replacement therapy (NRT), such as recent cardiovascular issues, you may be excluded from the trial.
What data supports the effectiveness of this treatment for smoking cessation?
Is Motivational Interviewing (MI) safe for smoking cessation?
How is the treatment NRT + Quit Practice Strategies for Smoking Cessation different from other treatments for smoking cessation?
This treatment is unique because it combines Motivational Interviewing (MI) Counseling, which helps people find their own reasons to quit smoking, with Practice Quitting (PQ) Counseling, which provides practical strategies for attempting to quit. This approach is different from other treatments that may focus solely on medication or more directive counseling methods.4791011
Research Team
Amanda R Mathew, PhD
Principal Investigator
Rush University Medical Center
Eligibility Criteria
This trial is for English-speaking adults in the continental U.S. who smoke daily (5+ cigarettes) and aren't planning to quit within 30 days but are considering quitting or reducing smoking within 6 months. They must have a smartphone for study procedures. It's not for those who vape daily, are pregnant/breastfeeding, or have had recent heart attacks or strokes.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PQ counseling vs. Motivational Interviewing and NRT sampling (four-week supply of nicotine lozenges and patches) vs. none
Follow-up
Participants are monitored for quit attempts and abstinence status at 1, 3, and 6 months
Treatment Details
Interventions
- Motivational Interviewing (MI) Counseling (Behavioural Intervention)
- Nicotine Replacement Therapy (NRT) Sampling (Nicotine Replacement Therapy)
- Practice Quitting (PQ) Counseling (Behavioural Intervention)
Motivational Interviewing (MI) Counseling is already approved in United States, Canada, European Union for the following indications:
- Smoking cessation
- Substance abuse treatment
- Smoking cessation
- Addiction treatment
- Smoking cessation
- Behavioral therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Medical University of South Carolina
Collaborator